Ironwood Pharmaceuticals Inc (IRWD)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Gross profit (ttm)	US$ in thousands	309,901	299,547	310,338	321,499	317,120	327,051	318,807	320,951	309,523	309,073	296,245	276,886	251,809	261,430	252,365	242,725	205,557	209,948	-1,966	-46,712
Revenue (ttm)	US$ in thousands	429,548	419,194	422,558	411,359	404,724	414,655	405,461	404,251	391,925	391,475	387,138	375,652	361,301	370,922	366,956	377,722	370,977	375,368	345,294	323,795
Gross profit margin		72.15%	71.46%	73.44%	78.16%	78.35%	78.87%	78.63%	79.39%	78.98%	78.95%	76.52%	73.71%	69.70%	70.48%	68.77%	64.26%	55.41%	55.93%	-0.57%	-14.43%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $309,901K ÷ $429,548K
= 72.15%

Ironwood Pharmaceuticals Inc has consistently maintained a gross profit margin of 100% throughout the past eight quarters, indicating that the company's profitability on its products or services sold is high. This suggests that Ironwood Pharmaceuticals Inc has been effectively controlling its production costs and markups on its products, resulting in a healthy margin between revenue and cost of goods sold. A steady gross profit margin at this level signals operational efficiency and effective pricing strategies, which could contribute to the company's financial stability and potential for future growth.